Ameke announced that on January 8, 2026, injectable botulinum toxin products produced by South Korea's Huons BioPharma Co., Ltd., which the company exclusively distributes in China, obtained the “Drug Registration Certificate” approved and issued by the State Drug Administration. The generic name of the drug is botulinum toxin type A for injection. The specification is 100U/bottle. The drug approval number is Sinopharm Standard SJ20260001, which is valid until January 4, 2031.

Zhitongcaijing · 3d ago
Ameke announced that on January 8, 2026, injectable botulinum toxin products produced by South Korea's Huons BioPharma Co., Ltd., which the company exclusively distributes in China, obtained the “Drug Registration Certificate” approved and issued by the State Drug Administration. The generic name of the drug is botulinum toxin type A for injection. The specification is 100U/bottle. The drug approval number is Sinopharm Standard SJ20260001, which is valid until January 4, 2031.